SCHEMBL21258474

SCHEMBL21258474

CCOCc1cnn2c(N(C)C(=O)OC(C)(C)C)cc(Cl)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20689679 0.87 HSP90AA1 (0.32) —
SCHEMBL20688924 0.82 KDM4E (0.44) —
SCHEMBL21948221 0.82 IRAK4 (0.33) —
SCHEMBL20678811 0.81 KDM4E (0.41) —
SCHEMBL20689134 0.81 PAX8 (0.31) —
SCHEMBL20627800 0.81 GSK3B (0.32) —
SCHEMBL25069828 0.81 SUV39H2 (0.34) —
SCHEMBL20689492 0.80 DPP4 (0.30) —
SCHEMBL20687904 0.79 TYK2 (0.37) —
SCHEMBL20689057 0.79 MALT1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177486-A1 TYK2 INHIBITORS AND USES THEREOF ALUMIS INC. 2022-06-09 — — US disclosed
US-10562907-B2 TYK2 inhibitors and uses thereof Nimbus Lakshimi, Inc. (US) 2020-02-18 — — US disclosed
US-20190248797-A1 TYK2 INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-08-15 — — US disclosed
Send feedback